US HHS Announces 'Operation TrialBlazer' to Accelerate Drug Development: FDA IND Reform to Shorten Time to Clinical Trials by 6-12 Months

On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced Operation TrialBlazer, a cross-agency initiative aimed at strengthening U.S. competitiveness in clinical research and accelerating new drug development. One of the core measures of this initiative is a fundamental review of the Investigational New Drug (IND) application process overseen by the U.S. Food and Drug Administration (FDA).